{
    "organizations": [],
    "uuid": "337af51f3c7ed7df6ca7d284eef26d6416f6cf8f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-volitionrx-announces-proposed-unde/brief-volitionrx-announces-proposed-underwritten-public-offering-idUSASB0C9JB",
    "ord_in_thread": 0,
    "title": "BRIEF-Volitionrx Announces Proposed Underwritten Public Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Volitionrx Ltd:\n* VOLITIONRX ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK\n* VOLITIONRX LTD - ‍INTENDS TO USE NET PROCEEDS OF OFFERING FOR CONTINUED PRODUCT DEVELOPMENT, CLINICAL STUDIES, PRODUCT COMMERCIALIZATION​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:18:00.000+02:00",
    "crawled": "2018-03-09T14:51:37.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "volitionrx",
        "ltd",
        "volitionrx",
        "announces",
        "proposed",
        "underwritten",
        "public",
        "offering",
        "common",
        "stock",
        "volitionrx",
        "ltd",
        "use",
        "net",
        "proceeds",
        "offering",
        "continued",
        "product",
        "development",
        "clinical",
        "study",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}